1,686
Views
20
CrossRef citations to date
0
Altmetric
Research Articles

Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation

, , , ORCID Icon, , , , , , , , , & show all
Pages 4532-4542 | Received 07 Sep 2020, Accepted 01 Dec 2020, Published online: 11 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mousikha Lala, Soumita Bhattacharjee, Chandra Ghosh, Arnab Sen & Indrani Sarkar. (2023) In-silico studies on wild orange (Citrus macroptera Mont.) compounds against COVID-19 pro-inflammation targets. Journal of Biomolecular Structure and Dynamics 41:8, pages 3511-3523.
Read now

Articles from other publishers (18)

Veena Paul, Abhishek Dutt Tripathi, Aparna Agarwal, Dipendra Kumar Mahato, Kartikeya Srivastava & Kamlesh Kumar Maurya. (2023) Herbs-derived phytochemicals – a boon for combating COVID-19. Vegetos.
Crossref
Shilpi Pathak, Neetu Agrawal & Ahsas Goyal. (2022) A Comprehensive Review on In Silico -predicted Potential Phytochemicals against SARS-CoV-2: Food for Thought for Researchers . Letters in Organic Chemistry 19:11, pages 931-957.
Crossref
Rishita Dey, Asmita Samadder & Sisir Nandi. (2022) Exploring the Targets of Novel Corona Virus and Docking-based Screening of Potential Natural Inhibitors to Combat COVID-19. Current Topics in Medicinal Chemistry 22:29, pages 2410-2434.
Crossref
Siva Swapna Kasarla, Swapnil P. Borse, Yashwant Kumar, Neha Sharma & Madhu Dikshit. (2022) In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19. Frontiers in Pharmacology 13.
Crossref
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei & Awat Feizi. (2022) Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies. Canadian Journal of Infectious Diseases and Medical Microbiology 2022, pages 1-70.
Crossref
Rajasekar Panchamoorthy & Prathinisha Prabhakar. (2022) Mucormycosis, a post-COVID infection: possible adjunctive herbal therapeutics for the realigning of impaired immune-metabolism in diabetic subjects. Herba Polonica 68:2, pages 86-98.
Crossref
Pallab Kar, Md. Moshfekus Saleh‐E‐In, Nishika Jaishee, Akash Anandraj, Emil Kormuth, Balachandar Vellingiri, Claudio Angione, Pattanathu K. S. M. Rahman, Suntheren Pillay, Arnab Sen, Devashan Naidoo, Ayan Roy & Yong E. Choi. (2022) Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS‐CoV‐2 wild‐type and the variants of concern, viral cell‐entry process, and cytokine storm in COVID‐19. Journal of Cellular Biochemistry 123:5, pages 964-986.
Crossref
Morteza Sadeghi & Mehran Miroliaei. (2022) Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study. In Silico Pharmacology 10:1.
Crossref
Neetu Agrawal & Ahsas Goyal. (2022) Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review. Current Pharmaceutical Biotechnology 23:3, pages 396-419.
Crossref
Swarnendra Banerjee, Pallab Kar, Indrani Sarkar, Abhijit Chhetri, Dipu Kumar Mishra, Ankita Dutta, Anoop Kumar, Biswajit Sinha & Arnab Sen. (2022) Structural elucidation and chemical characterization of underutilized fruit silverberry (Elaeagnus pyriformis) silver nanoparticles playing a dual role as anti-cancer agent by promoting apoptosis and inhibiting ABC transporters. South African Journal of Botany 145, pages 243-257.
Crossref
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian & Chonlaphat Sukasem. (2022) Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Frontiers in Pharmacology 13.
Crossref
Abhisek Jana, Tarun Roy, Sarbajit Layek, Subhas Ghosal & Deb Ranjan Banerjee. (2021) Computational Investigation on Natural Quinazoline Alkaloids as Potential Inhibitors of the Main Protease (Mpro) of SARS-CoV-2. Journal of Computational Biophysics and Chemistry 21:01, pages 65-82.
Crossref
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova & Paul Christakopoulos. (2022) Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds. Computational and Structural Biotechnology Journal 20, pages 1306-1344.
Crossref
Deepak Ganjewala, Hina Bansal, Ruchika Mittal & Gauri Srivastava. 2022. Herbal Medicines. Herbal Medicines 471 500 .
Rajasekar Panchamoorthy & Nethra Vel. (2021) Herbal spices-based therapeutics for diabetic patients with COVID-19 infection: A review. Natural Resources for Human Health 2:1, pages 32-51.
Crossref
Devashan Naidoo, Pallab Kar, Ayan Roy, Taurai Mutanda, Joseph Bwapwa, Arnab Sen & Akash Anandraj. (2021) Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations. Molecules 26:17, pages 5114.
Crossref
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, Maryam Naseri, Mohammad Hosein Farzaei & Javier Echeverría. (2021) Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-21.
Crossref
Fai‐Chu Wong, Joe‐Hui Ong & Tsun‐Thai Chai. (2020) Identification of Putative Cell‐entry‐inhibitory Peptides against SARS‐CoV‐2 from Edible Insects: An in silico Study . eFood 1:5, pages 357-368.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.